Pineridge Advisors LLC Has $34,000 Stock Holdings in Danaher Co. (NYSE:DHR)

Pineridge Advisors LLC grew its position in Danaher Co. (NYSE:DHR) by 63.3% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 147 shares of the conglomerate’s stock after buying an additional 57 shares during the period. Pineridge Advisors LLC’s holdings in Danaher were worth $34,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in DHR. Quilter Plc lifted its position in Danaher by 4.6% during the 4th quarter. Quilter Plc now owns 62,371 shares of the conglomerate’s stock valued at $14,317,000 after purchasing an additional 2,746 shares during the period. Elevate Capital Advisors LLC bought a new stake in shares of Danaher during the fourth quarter worth approximately $829,000. Angeles Wealth Management LLC lifted its holdings in Danaher by 5.1% in the fourth quarter. Angeles Wealth Management LLC now owns 4,229 shares of the conglomerate’s stock valued at $971,000 after buying an additional 204 shares during the period. Newbridge Financial Services Group Inc. acquired a new stake in Danaher during the 4th quarter worth $193,000. Finally, Kestra Private Wealth Services LLC raised its position in shares of Danaher by 11.2% during the 4th quarter. Kestra Private Wealth Services LLC now owns 17,480 shares of the conglomerate’s stock valued at $4,013,000 after acquiring an additional 1,754 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Guggenheim initiated coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price objective for the company. Raymond James restated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. TD Cowen increased their price target on shares of Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Stephens reaffirmed an “overweight” rating and issued a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Finally, Stifel Nicolaus lifted their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Seven equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Price Performance

NYSE DHR opened at $203.42 on Tuesday. Danaher Co. has a 12-month low of $203.00 and a 12-month high of $281.70. The firm’s 50 day moving average is $232.72 and its 200-day moving average is $251.61. The company has a market capitalization of $146.92 billion, a PE ratio of 38.53, a price-to-earnings-growth ratio of 2.68 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the firm posted $2.09 EPS. Equities research analysts anticipate that Danaher Co. will post 7.67 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a $0.27 dividend. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.53%. Danaher’s dividend payout ratio is 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.